| HOME >> MEDICINE >> TECHNOLOGY |
2,458Short-term investments175,245
128,054Accounts receivable, net99,578
72,736Inventories47,774
45,351Prepaid expenses and other current assets18,807
15,133Total current assets395,960
335,100Non-current assets:Goodwill32,561
34,701Property, plant and equipment, net264,381
245,694Long-term investments14,015
4,335Intangible assets, net7,268
10,568Land use rights5,564
5,488Deferred tax assets3,037
8,499Other non-current assets19,749
19,469Total non-current assets346,575
328,754Total assets742,535
663,854Liabilities and equity:Current liabilities:Short-term and current portion of long-term debt59,089
28,661Accounts payable21,808
22,803Accrued expenses27,411
20,913Deferred revenue17,052
15,881Advanced subsidies9,265
6,417Other taxes payable1,581
2,196Convertible notes-
35,864Other current liabilities11,215
10,018Total current liabilities147,421
142,753Non-current liabilities:Long-term debt, excluding current portion5,697
1,646Advanced subsidies2,663
3,215Long-term payable732
3,944Other non-current liabilities7,799
6,570Total non-current liabilities16,891
15,375Total liabilities164,312
158,128Equity:Ordinary shares ($0.02 par value, 5,002,550,000
authorized, 570,489,352 and 561,121,002 issued and
outstanding as of December 31, 2011, and December 31,
2012, respectively) 11,222
11,410Additional paid-in capital331,715
345,832Retained earnings188,604
103,159Accumulated other comprehensive income46,682
45,325Total equity578,223
505,726Total liabilities and equity742,535
663,854 WUXI PHARMATECH (CAYMAN) INC.UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME(In thousands of U.S. dollars
'/>"/>
| SOURCE Wuxi PharmaTech Co. Ltd. Copyright©2012 PR Newswire. All rights reserved |